{
    "clinical_study": {
        "@rank": "114122", 
        "arm_group": [
            {
                "arm_group_label": "Multiple dose mtx", 
                "arm_group_type": "Experimental", 
                "description": "mtx"
            }, 
            {
                "arm_group_label": "Single Dose", 
                "arm_group_type": "Experimental", 
                "description": "In the single dose regimen, 50 mg/m2 intramuscular methotrexate was given on day one and hCG level was measured on days four and seven. If the hCG level did not decrease by 15% between day four and seven, a second dose of methotrexate was injected on day seven, hCG level was measured weekly until a level of 15 mlU/ml or less was achieved"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study was to compare single dose Methotrexate (MTX) to multiple dose MTX."
        }, 
        "brief_title": "Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy", 
        "completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "condition": "Pregnancy, Ectopic", 
        "condition_browse": {
            "mesh_term": [
                "Pregnancy, Ectopic", 
                "Cardiac Complexes, Premature"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  unruptured tubal EP\n\n          -  gestational mass of less than or equal to 3.5 cm in ultrasonography report\n\n        Exclusion Criteria:\n\n          -  hemodynamic instability\n\n          -  contraindications related to the use of MTX\n\n          -  hepatic\n\n          -  renal and active pulmonary diseases\n\n          -  peptic ulcer\n\n          -  immune deficiency status\n\n          -  alcohol abuse\n\n          -  blood dyscreasia"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "87", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01662167", 
            "org_study_id": "U1111-1133-3069"
        }, 
        "intervention": [
            {
                "arm_group_label": "Single Dose", 
                "description": "In the single dose regimen, 50 mg/m2 intramuscular methotrexate was given on day one and hCG level was measured on days four and seven. If the hCG level did not decrease by 15% between day four and seven, a second dose of methotrexate was injected on day seven, hCG level was measured weekly until a level of 15 mlU/ml or less was achieved", 
                "intervention_name": "Single", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Multiple dose mtx", 
                "description": "In the multiple dose regimen, 1 mg/kg/day intramuscular methotrexate was given on days one, three, five and seven and 0.1 mg/kg/day intramuscular Citrovoram factor was administered on days two, four, six and eight until serum hCG level decreased 15% in 48 hours or four doses of methotrexate was given weekly until serum hCG level of 15 mlU/ml or less was obtained", 
                "intervention_name": "Multipe", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methotrexate"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 9, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bandar Abbas", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Hormozgan", 
                    "zip": "79761"
                }, 
                "name": "Shariaty Hospital"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy: a Clinical Trail", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Hormozgan University of Medical Sciences"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "hCG level decrease", 
            "safety_issue": "No", 
            "time_frame": "4 days after administration"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01662167"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hormozgan University of Medical Sciences", 
            "investigator_full_name": "Mohammad E Shahrzad, MD", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hormozgan University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hormozgan University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}